Pemetrexed for the treatment of malignant pleural mesothelioma

  • Technology appraisal guidance
  • TA135
  • Published: 
Download guidance (PDF)

Update information

Minor changes since publication

March 2014: Implementation section updated to clarify that pemetrexed is recommended as an option for treating malignant pleural mesothelioma.

ISBN: 978-1-4731-5675-3